QR-koodi

Medication Adherence and Antithrombotic Therapy Outcomes

Background: The AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease) trial demonstrated that rivaroxaban monotherapy has noninferior efficacy and superior safety compared with combination therapy (rivaroxaban plus a single antiplatelet) in...

Täydet tiedot

Tallennettuna:
Päätekijät: Naoki Chiba, MD, Takashi Noda, MD, PhD, Kotaro Nochioka, MD, PhD, Koichi Kaikita, MD, PhD, Masaharu Akao, MD, PhD, Junya Ako, MD, PhD, Tetsuya Matoba, MD, PhD, Masato Nakamura, MD, PhD, Katsumi Miyauchi, MD, PhD, Nobuhisa Hagiwara, MD, PhD, Kazuo Kimura, MD, PhD, Kunihiko Matsui, MD, MPH, Hisao Ogawa, MD, PhD, Satoshi Yasuda, MD, PhD
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2026-03-01
Sarja:JACC: Asia
Aiheet:
atrial fibrillation
bleeding
coronary artery disease
medication adherence
monotherapy
Linkit:http://www.sciencedirect.com/science/article/pii/S2772374725007045
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia